Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    GSK

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Glaxo Wellcome London GB

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Glaxo Wellcome London GB

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Griseofulvin

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    R0-CEP 2000-374 - Rev 01
    Withdrawn by Holder
    TSE
    2001-11-21
    2006-07-11
    182
    blank

    01

    Glaxo Wellcome London GB

    United Kingdom
    Compamed
    Not Confirmed
    arrow

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-374 - Rev 01 of Glaxo Wellcome London Gb

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-374 - Rev 01 of Glaxo Wellcome London Gb 1

    20

    Glaxo Wellcome London Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Griseofulvin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2000-374 - Rev 01

    This TSE Type CEP, issued on November 21, 2001, remains in force until July 11, 2006, ensuring its reliability within the pharmaceutical industry.

    Substance Number 182 associated with this CEP further emphasizes